SCHEMBL15870558

SCHEMBL15870558

OC[C@H](Nc1cncc(-c2cccc(O)c2)c1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.62
▸ CDK8 P49336 2/20 0.62
▸ FGFR1 P11362 3/20 0.50
▸ FGFR2 P21802 3/20 0.50
▸ FGFR3 P22607 3/20 0.50
▸ FYN P06241 1/20 0.47
▸ FDPS P14324 1/20 0.46
▸ MAPKAPK2 P49137 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ CDK7 P50613 1/20 0.45
▸ EGFR P00533 6/20 0.44
▸ CCNT1 O60563 2/20 0.43
▸ CDK9 P50750 2/20 0.43
▸ CYP17A1 P05093 1/20 0.42
▸ DHPS P49366 1/20 0.42
▸ ABL1 P00519 1/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ INSR P06213 1/20 0.41
▸ RET P07949 1/20 0.41
▸ MET P08581 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15870580 0.86 CCNC (0.61) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15870512 0.86 CCNC (0.61) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15870532 0.86 CCNC (0.63) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15864390 0.83 CCNC (0.58) CCNCCDK8FGFR2FDPSCDK2
SCHEMBL15864387 0.83 CCNC (0.58) CCNCCDK8FGFR2FDPSCDK2
SCHEMBL15870517 0.82 CCNC (0.62) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15864598 0.82 CCNC (0.66) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15870505 0.82 CCNC (0.62) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15870511 0.81 CCNC (0.53) CCNCCDK8FGFR1FGFR2FGFR3
SCHEMBL15870552 0.81 CCNC (0.64) CCNCCDK8FGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 — — WO disclosed
Send feedback